Shareholders of Harris & Harris Group, Inc., may be interested to read the article entitled, "Gauging Nanobiotech's Promise Realistically," by K. John Morrow in the December 1, 2006, issue of Genetic Engineering News magazine. The article discusses a number of companies developing nanotechnology-enabled products for the biotech industry including Evolved Nanomaterial Sciences, a portfolio company of Harris & Harris Group. The article may be read at http://www.genengnews.com/articles/chitem.aspx?aid=1953.
Harris & Harris Group invested $2,800,000 in Evolved Nanomaterial Sciences, Inc. (ENS) as part of an $3.3 million Series A financing. ENS has developed a number of nanotechnology-enhanced approaches for the resolution of chiral molecules. ENS is using its proprietary ESPTM technology to manufacture high-capacity, high-generality HPLC columns that simplify chiral method development and chiral chromatography and purification.
Harris & Harris Group is a publicly traded venture capital company that makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 30 initial private equity investments have been in tiny technology-enabled companies. The Company has 20,756,345 common shares outstanding.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.TinyTechVC.com.
This news release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this news release. Please see the Company's Registration Statement on Form N-2 and Annual Report on Form 10-K for the year ended December 31, 2005, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the websites www.TinyTechVC.com and www.genengnews.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this news release.
CONTACT: CHARLES E. HARRIS
TEL. NO. (212) 582-0900